# A Trial In Patients With Advanced Cancer And Leukemia

> **NCT00878189** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 72 (actual)

## Conditions studied

- Neoplasms by Histologic Type

## Interventions

- **DRUG:** PF-03084014

## Key facts

- **NCT ID:** NCT00878189
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-25
- **Primary completion:** 2013-01-10
- **Final completion:** 2016-11-22
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878189, "A Trial In Patients With Advanced Cancer And Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00878189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
